Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer

被引：0
作者：
Shailesh Mahesh Advani
Pragati Shailesh Advani
Derek W. Brown
Stacia M. DeSantis
Krittiya Korphaisarn
Helena M. VonVille
Jan Bressler
David S. Lopez
Jennifer S. Davis
Carrie R. Daniel
Amir Mehrvarz Sarshekeh
Dejana Braithwaite
Michael D. Swartz
Scott Kopetz
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal Medical Oncology
[2] Georgetown University,Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center
[3] National Institute of Health,Social Behavioral Research Branch, National Human Genome Research Institute
[4] National Institutes of Health,Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics
[5] National Cancer Institute,Department of Biostatistics and Data Science, School of Public Health
[6] The University of Texas Health Science Center at Houston,Library, School of Public Health
[7] The University of Texas Health Science Center at Houston,Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health
[8] The University of Texas Health Science Center at Houston,Department of Preventive Medicine and Community Health
[9] Division of Urology- UTHealth McGovern Medical School,Department of Epidemiology
[10] UTMB Health-School of Medicine,undefined
[11] The University of Texas MD Anderson Cancer Center,undefined
来源：
BMC Cancer | / 19卷
关键词：
Epigenetics; Methylation; Geographic; CIMP; Colorectal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 860 条
  • [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-EE86
  • [2] Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-731
  • [3] Soerjomataram I(2009)Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors Clin Colon Rectal Surg 22 191-8686
  • [4] Siegel RL(2016)Tracking the correlation between CpG island methylator phenotype and other molecular features and clinicopathological features in human colorectal cancers: a systematic review and meta-analysis Clin Transl Gastroenterol 7 e151-364
  • [5] Torre LA(2010)A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy Oncologist. 15 699-2327
  • [6] Jemal A(1999)CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci U S A 96 8681-85
  • [7] Ferlay J(2009)Serrated polyps and colorectal cancer: new pathway to malignancy Annu Rev Pathol 4 343-793
  • [8] Soerjomataram I(2014)Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis Ann Oncol 25 2314-314
  • [9] Dikshit R(2012)The CpG island methylator phenotype in colorectal cancer: progress and problems Biochim Biophys Acta 1825 77-282
  • [10] Eser S(2016)Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review Clin Epigenetics 8 25-1854
12345678910